Ginkgo biloba extract , Ginkgo biloba P.E

본문 바로가기


Home > Product > Ginkgo biloba extract , Ginkgo biloba P.E
Product
Ginkgo biloba extract , Ginkgo biloba P.E
Posting date : Dec 02, 2013
Membership
Free Member Scince Nov 25, 2013
Keyword :
Category
Contact
          0 likes     
Product Detail
Company Info
 
Quick Detail
Place of Origin
HS-CODE
30-
Package & Delivery Lead Time
Detailed Description
Product Name Ginkgo Biloba Extract Latin Name Ginkgo Biloba L. CAS NO. 90045-36-6 Part of used Leaf Appearance Brownish yellow fine powder Specification 24%/6%Flavonoides/Lactone CP10 Active Ingredient Quercetin11.5% Kaempferol12.5% Isorhamnetin1.74% Ginkgolide A 1.84% Ginkgolide B 0.77% Ginkgolide C 1.62% Bilobalide 2.3% Test Method HPLC Application Pharmaceutical, health products, cosmetic Certificate ISO9001(SGS), UKAS, GMP(NSF), KOSHER, HALAL, FDA Packing Small quantity with double plastic-bag inside and aluminum foil bag outside. Large quantity with 25kg/drum, or depends on clients requirement. Storage Store in cool and dry place and avoid light and heat. Shelf Life 24 months Benefits 1.Improving blood circulation 2.Treating coronary disease and angina pectoris 3.Treating acute cerebral infarction (ACI) 4.Antioxidant 5.Antiaging 6.Relieving premenstrual syndrome(PMS) 7.Improving sexual function 8.Protecting eyesight, treating retinal arteriosclerosis 9.Lowering high blood pressure, treating diabetes and senile dementia. Introduction Ginkgo Biloba Extract contain flavonoid glycosides (myricetin and quercetin) and terpenoids (ginkgolides, bilobalides). These extracts are shown to exhibit reversible, nonselective monoamine oxidase inhibition, as well as inhibition of reuptake at the serotonin, dopamine, and norepinephrine transporters, with all but the norepinephrine reuptake inhibition fading in chronic exposure. Ginkgo extract has in addition been found to act as a selective 5-HT1A receptor agonist in vivo. In 2010, a meta-analysis of clinical trials has shown Ginkgo to be moderately effective in improving cognition in dementia patients but not preventing the onset of Alzheimer's disease in people without dementia.

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top